Related Experiment Videos
[Quantitative chloramphenicol detection in serum and cerebrospinal fluid of infants with bacterial meningitis]
1Institut für Klinische Pharmakologie, Medizinischen Akademie Magdeburg.
Insights
This study on infant meningitis treatment found that chloramphenicol dosage needs careful adjustment. Age-based dosing initially, followed by monitoring serum and cerebrospinal fluid levels, ensures optimal treatment for infants.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacokinetics in Infants
- Antibiotic Therapy
Context:
- Bacterial meningitis in infants requires effective antibiotic treatment.
- Chloramphenicol is a potential antibiotic for treating infant meningitis.
- Accurate dosing is crucial for efficacy and safety in neonates and infants.
Purpose:
- To evaluate the relationship between chloramphenicol dosage, serum levels, and cerebrospinal fluid (CSF) concentrations in infants with meningitis.
- To establish evidence-based dosing recommendations for chloramphenicol in treating infant meningitis.
Summary:
- Twenty-six infants under one year with meningitis received daily chloramphenicol doses (44-170 mg/kg).
- Serum levels ranged from 5.4-55.0 µg/mL, and CSF concentrations were 0.9-20.2 µg/mL.
- A clear dose-serum level relationship was not observed, especially in younger infants, and CSF levels could not be reliably predicted from serum levels.
Impact:
- Recommends initial age-adjusted chloramphenicol dosing for infants with meningitis.
- Suggests adjusting subsequent doses based on CSF (>10 µg/mL) and serum (<50 µg/mL) levels from day 2 onwards.
- Aims to optimize therapeutic drug monitoring for improved outcomes in infant meningitis treatment.
Abstract:
Twenty-six meningitic infants aged less than one year were administered daily oral or intravenous doses from 44 to 170 mg chloramphenicol per kg body weight. Serum levels measured were 5.4 to 55.0 micrograms.ml-1, and CSF concentrations from 0.9 to 20.2 micrograms.ml-1 were noted. Since, in particular for younger infants, (i) there is no clear relationship between dose and blood level and (ii) one cannot unambiguously infer the CSF concentration from the blood level we recommend that initial doses for meningitic infants be chosen according to age-adjusted dosage instructions and, from day 2 onwards, doses be corrected as a function of CSF and blood levels (CSF greater than 10 micrograms.ml-1 and serum less than 50 micrograms.ml-1).